Sign up to receive e-mail updates on a type of Chronic Dry Eye disease, treatment, and other eye health topics

*Required Information









*Yes, I would like to receive information about RESTASIS® and other products and disease states from Allergan. I understand that I can opt-out of receiving e-mails at any time by clicking the unsubscribe link in any e-mail.

See Allergan's Privacy Statement



 

Approved Use

RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion help increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® and RESTASIS MultiDose® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.

Important Safety Information

Do not use RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion if you are allergic to any of the ingredients. Be careful not to touch the container tip to your eye or other surfaces, to help avoid eye injury and contamination. RESTASIS® and RESTASIS MultiDose® should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to use of RESTASIS® and RESTASIS MultiDose® and may be reinserted after 15 minutes.

The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for full Product Information for RESTASIS® and RESTASIS MultiDose®.

View Desktop

Privacy Statement  |  Terms of Use  |  Contact Us  |
RES110169_v6 08/18   © 2018 Allergan, Inc. All rights reserved. This information is intended for residents of the United States. All trademarks are the property of their respective owners.

Approved Use

RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion help increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® and RESTASIS MultiDose® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.

Important Safety Information

Do not use RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion if you are allergic to any of the ingredients. Be careful not to touch the container tip to your eye or other surfaces, to help avoid eye injury and contamination. RESTASIS® and RESTASIS MultiDose® should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to use of RESTASIS® and RESTASIS MultiDose® and may be reinserted after 15 minutes.

The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for full Product Information for RESTASIS® and RESTASIS MultiDose®.

View Desktop

Privacy Statement  |  Terms of Use  |  Contact Us  |
RES110169_v6 08/18   © 2018 Allergan, Inc. All rights reserved. This information is intended for residents of the United States. All trademarks are the property of their respective owners.